Literature DB >> 11093613

Predictive factors for the severity of tinnitus.

K M Holgers1, S I Erlandsson, M L Barrenäs.   

Abstract

The majority of patients with tinnitus experience a lessening of their symptoms during an 18-month period after their first consultation. The exception to this rule is severe incapacitating tinnitus, the sometimes very troublesome symptoms of which show no sign of diminishing with time. The aim of the present study was to investigate risk factors for incapacitating tinnitus, as measured by absence from work related to tinnitus (AWT) of more than 1 month during an 18-month period after the first visit to the tinnitus clinic. Audiometric data and the scores from the Tinnitus Severity Questionnaire and the Nottingham Health Profile at the first visit to the clinic were correlated to AWT by a logistic regression model. By using this risk model, an individual risk score for AWT could be estimated. Depression and physical immobility were strong predictors of AWT, and hearing loss was moderate. Based on these results, we suggest that the aetiology of tinnitus severity could be described as depression-/anxiety-related, somatic, and auditory tinnitus.

Entities:  

Mesh:

Year:  2000        PMID: 11093613     DOI: 10.3109/00206090009073093

Source DB:  PubMed          Journal:  Audiology        ISSN: 0020-6091


  18 in total

1.  Tinnitus in 7-year-old children.

Authors:  Kajsa-Mia Holgers
Journal:  Eur J Pediatr       Date:  2003-02-26       Impact factor: 3.183

2.  Cortisol suppression and hearing thresholds in tinnitus after low-dose dexamethasone challenge.

Authors:  Veerle L Simoens; Sylvie Hébert
Journal:  BMC Ear Nose Throat Disord       Date:  2012-03-26

Review 3.  [The significance of stress: its role in the auditory system and the pathogenesis of tinnitus].

Authors:  B Mazurek; T Stöver; H Haupt; B F Klapp; M Adli; J Gross; A J Szczepek
Journal:  HNO       Date:  2010-02       Impact factor: 1.284

4.  Hearing loss and tinnitus in survivors with chemotherapy-induced neuropathy.

Authors:  Christine Miaskowski; Steven M Paul; Judy Mastick; Mark Schumacher; Yvette P Conley; Betty Smoot; Gary Abrams; Kord M Kober; Steven Cheung; Jennifer Henderson-Sabes; Margaret Chesney; Melissa Mazor; Margaret Wallhagen; Jon D Levine
Journal:  Eur J Oncol Nurs       Date:  2017-11-07       Impact factor: 2.398

5.  Assessment of psychopathological aspects and psychiatric comorbidities in patients affected by tinnitus.

Authors:  Seyda Belli; Hasan Belli; Talat Bahcebasi; Adnan Ozcetin; Emrehan Alpay; Umit Ertem
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-13       Impact factor: 2.503

6.  Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.

Authors:  Christine Miaskowski; Judy Mastick; Steven M Paul; Gary Abrams; Steven Cheung; Jennifer Henderson Sabes; Kord M Kober; Mark Schumacher; Yvette P Conley; Kimberly Topp; Betty Smoot; Grace Mausisa; Melissa Mazor; Margaret Wallhagen; Jon D Levine
Journal:  J Cancer Surviv       Date:  2017-11-20       Impact factor: 4.442

7.  [Psychological stress and impaired quality of life in patients with tinnitus].

Authors:  M Härter; C Maurischat; G Weske; R Laszig; M Berger
Journal:  HNO       Date:  2004-02       Impact factor: 1.284

Review 8.  Hearing difficulties, ear-related diagnoses and sickness absence or disability pension--a systematic literature review.

Authors:  Emilie Friberg; Klas Gustafsson; Kristina Alexanderson
Journal:  BMC Public Health       Date:  2012-09-12       Impact factor: 3.295

9.  Tinnitus severity is reduced with reduction of depressive mood--a prospective population study in Sweden.

Authors:  Sylvie Hébert; Barbara Canlon; Dan Hasson; Linda L Magnusson Hanson; Hugo Westerlund; Töres Theorell
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

10.  Do patient characteristics predict outcome in the outpatient treatment of chronic tinnitus?

Authors:  Birgit Kröner-Herwig; Claudia Zachriat; Doreen Weigand
Journal:  Psychosoc Med       Date:  2006-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.